The Chairwoman of the Board of Sino Biopharmaceutical Limited is Ms. Theresa Tse, who has successfully led the enterprise in this executive capacity since 2015. Under her strategic direction, the company has driven extensive structural transformations, focusing heavily on innovative drug research and development, global pharmaceutical partnerships, and precise international acquisitions. Her leadership has earned her widespread recognition, including multiple inclusions on Forbes China's list of Top 100 Outstanding Businesswomen.